172 related articles for article (PubMed ID: 10222066)
1. CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors.
Kim CH; Pelus LM; Appelbaum E; Johanson K; Anzai N; Broxmeyer HE
Cell Immunol; 1999 May; 193(2):226-35. PubMed ID: 10222066
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
[TBL] [Abstract][Full Text] [Related]
3. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation.
Kim CH; Broxmeyer HE
J Leukoc Biol; 1999 Sep; 66(3):455-61. PubMed ID: 10496316
[TBL] [Abstract][Full Text] [Related]
4. CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells.
Kim CH; Pelus LM; White JR; Applebaum E; Johanson K; Broxmeyer HE
J Immunol; 1998 Mar; 160(5):2418-24. PubMed ID: 9498785
[TBL] [Abstract][Full Text] [Related]
5. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells.
Kellermann SA; Hudak S; Oldham ER; Liu YJ; McEvoy LM
J Immunol; 1999 Apr; 162(7):3859-64. PubMed ID: 10201903
[TBL] [Abstract][Full Text] [Related]
6. Developmental stage-specific shift in responsiveness to chemokines during human B-cell development.
Honczarenko M; Glodek AM; Swierkowski M; Na IK; Silberstein LE
Exp Hematol; 2006 Aug; 34(8):1093-100. PubMed ID: 16863916
[TBL] [Abstract][Full Text] [Related]
7. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7.
Campbell JJ; Bowman EP; Murphy K; Youngman KR; Siani MA; Thompson DA; Wu L; Zlotnik A; Butcher EC
J Cell Biol; 1998 May; 141(4):1053-9. PubMed ID: 9585422
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells.
Kim CH; Pelus LM; White JR; Broxmeyer HE
J Immunol; 1998 Sep; 161(5):2580-5. PubMed ID: 9725259
[TBL] [Abstract][Full Text] [Related]
9. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.
Yoshida R; Nagira M; Kitaura M; Imagawa N; Imai T; Yoshie O
J Biol Chem; 1998 Mar; 273(12):7118-22. PubMed ID: 9507024
[TBL] [Abstract][Full Text] [Related]
10. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease.
Kawashima D; Oshitani N; Jinno Y; Watanabe K; Nakamura S; Higuchi K; Arakawa T
J Clin Pathol; 2005 Oct; 58(10):1057-63. PubMed ID: 16189151
[TBL] [Abstract][Full Text] [Related]
11. CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues.
Votta BJ; White JR; Dodds RA; James IE; Connor JR; Lee-Rykaczewski E; Eichman CF; Kumar S; Lark MW; Gowen M
J Cell Physiol; 2000 May; 183(2):196-207. PubMed ID: 10737895
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
Alt C; Laschinger M; Engelhardt B
Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors.
Jenh CH; Cox MA; Kaminski H; Zhang M; Byrnes H; Fine J; Lundell D; Chou CC; Narula SK; Zavodny PJ
J Immunol; 1999 Apr; 162(7):3765-9. PubMed ID: 10201891
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
[TBL] [Abstract][Full Text] [Related]
15. Enhanced HIV-1 replication by chemokines constitutively expressed in secondary lymphoid tissues.
Nagira M; Sato A; Miki S; Imai T; Yoshie O
Virology; 1999 Nov; 264(2):422-6. PubMed ID: 10562503
[TBL] [Abstract][Full Text] [Related]
16. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7.
Willimann K; Legler DF; Loetscher M; Roos RS; Delgado MB; Clark-Lewis I; Baggiolini M; Moser B
Eur J Immunol; 1998 Jun; 28(6):2025-34. PubMed ID: 9645384
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: developmental switches in chemokine responses during T cell maturation.
Campbell JJ; Pan J; Butcher EC
J Immunol; 1999 Sep; 163(5):2353-7. PubMed ID: 10452965
[TBL] [Abstract][Full Text] [Related]
18. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta).
Ott TR; Lio FM; Olshefski D; Liu XJ; Struthers RS; Ling N
Biochemistry; 2004 Mar; 43(12):3670-8. PubMed ID: 15035637
[TBL] [Abstract][Full Text] [Related]
19. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
Lotzová E; Savary CA; Champlin RE
J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties.
Sozzani S; Allavena P; D'Amico G; Luini W; Bianchi G; Kataura M; Imai T; Yoshie O; Bonecchi R; Mantovani A
J Immunol; 1998 Aug; 161(3):1083-6. PubMed ID: 9686565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
